摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8-iodo-2-methyl-N,N-dipropylquinolin-4-amine | 620179-10-4

中文名称
——
中文别名
——
英文名称
8-iodo-2-methyl-N,N-dipropylquinolin-4-amine
英文别名
——
8-iodo-2-methyl-N,N-dipropylquinolin-4-amine化学式
CAS
620179-10-4
化学式
C16H21IN2
mdl
——
分子量
368.261
InChiKey
OIBZFFQGEOXMSY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.2
  • 重原子数:
    19
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.44
  • 拓扑面积:
    16.1
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    2,4-二甲氧基苯硼酸8-iodo-2-methyl-N,N-dipropylquinolin-4-amine四(三苯基膦)钯sodium carbonate 作用下, 以 乙醇 为溶剂, 生成 [8-(2,4-Dimethoxy-phenyl)-2-methyl-quinolin-4-yl]-dipropyl-amine
    参考文献:
    名称:
    Synthesis and SAR of 8-Arylquinolines as potent corticotropin-Releasing factor1 (CRF1) receptor antagonists
    摘要:
    A series of 4-substituted 8-aryl-2-methylquinolines 4 was designed and synthesized as highly potent antagonists for the human CRF1 receptor. This series of compounds displayed parallel SAR to other bicyclic systems such as pyrazolo[l,5-a]pyrimidines, with several compounds possessing low nanomolar binding affinity. In addition to the high potency, the basicity of this 4-aminoquinoline core may offer CRF1 antagonists with lower lipophilicity. (C) 2003 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(03)00684-x
  • 作为产物:
    描述:
    参考文献:
    名称:
    Synthesis and SAR of 8-Arylquinolines as potent corticotropin-Releasing factor1 (CRF1) receptor antagonists
    摘要:
    A series of 4-substituted 8-aryl-2-methylquinolines 4 was designed and synthesized as highly potent antagonists for the human CRF1 receptor. This series of compounds displayed parallel SAR to other bicyclic systems such as pyrazolo[l,5-a]pyrimidines, with several compounds possessing low nanomolar binding affinity. In addition to the high potency, the basicity of this 4-aminoquinoline core may offer CRF1 antagonists with lower lipophilicity. (C) 2003 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(03)00684-x
点击查看最新优质反应信息